Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Interest Expenses (2018 - 2025)

Puma Biotechnology's Interest Expenses history spans 8 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Interest Expenses fell 57.31% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $6.6 million, down 46.82%, while the annual FY2025 figure was $6.6 million, 46.82% down from the prior year.
  • Interest Expenses reached $1.1 million in Q4 2025 per PBYI's latest filing, down from $1.5 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $3.5 million in Q2 2021 to a low of $1.1 million in Q4 2025.
  • Average Interest Expenses over 5 years is $2.8 million, with a median of $3.1 million recorded in 2021.
  • Peak YoY movement for Interest Expenses: increased 24.32% in 2023, then tumbled 57.31% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $2.7 million in 2021, then increased by 20.64% to $3.3 million in 2022, then increased by 2.29% to $3.4 million in 2023, then dropped by 21.85% to $2.6 million in 2024, then crashed by 57.31% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Interest Expenses are $1.1 million (Q4 2025), $1.5 million (Q3 2025), and $1.8 million (Q2 2025).